MindWalk Holdings (HYFT) Current Taxes (2020 - 2026)
MindWalk Holdings (HYFT) reported Current Taxes of $236346.9 for Q1 2026, up 66.1% year-over-year from $142294.2 in Q1 2025, and down 22.86% quarter-over-quarter from $306373.6 in Q4 2025.
MindWalk Holdings (HYFT) Current Taxes (2020 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has 7 years of Current Taxes data on file, last reported at $236346.9 in Q1 2026.
- Current Taxes for Q1 2026 came in at $236346.9, up 66.1% year-over-year; the trailing twelve-month figure through Jan 2026 was $236346.9 (up 66.1% YoY), and the FY2025 annual result was $340996.5, down 16.39% from the prior year.
- Current Taxes eased to $236346.9 in Q1 2026 per HYFT's latest filing, from $306373.6 in the prior quarter.
- Over five years, Current Taxes peaked at $464568.0 in Q1 2022 and troughed at $1478.1 in Q2 2023.
- A 5-year average of $240778.8 and a median of $260896.8 in 2023 frame the typical range for Current Taxes.
- The sharpest annual moves came in 2023 and 2024: Current Taxes slumped 99.55% in 2023, then soared 27492.8% in 2024.
- A 5-year view of Current Taxes shows it stood at $23339.8 in 2022, then jumped by 1685.3% to $416684.0 in 2023, then sank by 54.83% to $188198.2 in 2024, then soared by 62.79% to $306373.6 in 2025, then declined by 22.86% to $236346.9 in 2026.
- Business Quant data shows HYFT's Current Taxes at $236346.9 in Q1 2026, $306373.6 in Q4 2025, and $333796.1 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 10,460.56 |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 19.20 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | MindWalk Holdings | 166.20 Mn | 156.06 Mn | 1.78 | 236,346.86 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 236,346.86 |
| Oct 31, 2025 | 306,373.58 |
| Apr 30, 2025 | 333,796.13 |
| Jan 31, 2025 | 142,294.22 |
| Oct 31, 2024 | 188,198.20 |
| Jul 31, 2024 | 408,974.71 |
| Apr 30, 2024 | 407,848.71 |
| Jan 31, 2024 | 155,341.51 |
| Oct 31, 2023 | 416,684.05 |
| Jul 31, 2023 | 285,446.65 |
| Apr 30, 2023 | 1,478.10 |
| Jan 31, 2023 | 77,846.41 |
| Oct 31, 2022 | 23,339.76 |
| Jul 31, 2022 | 72,310.02 |
| Apr 30, 2022 | 331,613.16 |
| Jan 31, 2022 | 464,568.00 |
| Oct 31, 2021 | 322,152.30 |
| Jul 31, 2021 | 45,583.05 |
| Apr 30, 2021 | 258,941.00 |
| Jan 31, 2021 | 447,982.69 |